| Prev Close | 108.51 |
| Day Low/High | 107.96 / 108.91 |
| 52 Wk Low/High | 81.66 / 112.05 |
| Avg Volume | 4.39M |
Medtronic Plc (MDT)
108.12
NYSE : Health Technology
| Exchange | NYSE |
| Shares Outstanding | 1.34B |
| Market Cap | 145.58B |
| EPS | 3.40 |
| P/E Ratio | 32.98 |
| Div & Yield | 2.16 (1.92%) |
Latest News
Profit Taking, Rate Cuts and a Play on Zscaler: Market Recon
Evaluating the market and policy discussion ahead of Jackson Hole, and how I am playing Zscaler on this weakness.
Real Money Post-Industrial Average Leads Major Indexes So Far for Year
In July, the RMPIA climbed 0.6%, bringing its year-to-date return to just over 21%.
Dexcom Looks Like It Can Finally Break Out on the Topside
Let's check the charts and indicators on the glucose-monitoring company.
Real Money Post-Industrial Index Continues to Outperform Major Market Indices
Amid May's market turbulence, the RMPIA was buoyed by the more than 4% rise from Medtronic.
Medtronic Is Edging Closer to an Upside Breakout on the Charts
No one knows their business as well as the CEO.
Trade War Heats Up, Fundamental Analysis, Boeing on the Hot Seat: Market Recon
China's President Xi has obviously found surrender distasteful.
Jim Cramer: AAPL Should Get Into Diabetes Treatment and KHC Should Invest in Pot
In this day and age, companies must be 'disruptors' or get left in the dust.
A Technical Strategy for Tandem Diabetes Care
Are we late to the game with the stock up so much?
Real Money Post-Industrial Average Shines in January, Outperforming S&P 500
RMPIA soared 9.9% for the month, led by 11 double-digit gainers.
Medtronic Stock Is Showing Promise on the Daily Chart
Here's how to trade MDT, going long.
8 Top Year-End Trading Ideas for Bargain Hunters
These eight S&P 500 stocks have some of the worst returns year-to-date and represent a diverse roster of promising bounce candidates.
Medtronic Is Testing the 200-Day Average and I Am Not Too Optimistic
Prices are testing the October and November lows and also testing the rising 200-day moving average line.
Rattled? The Only Obstacle Is the One in Front of You: Market Recon
Everyone gets knocked down. What is different about you is that you are as tough as these markets.
Real Money Post-Industrial Average Beat Nasdaq Comp in November's First Half
Our index of 30 cutting-edge companies fell ... but not as much as the Nasdaq did.
Jim Cramer: Know Which Way the Wind Blows Before You Pick Stocks
PepsiCo, GE and just like the weather, the stock market is subject to change.
Jim Cramer: These Are the Stocks to Buy on Canada Deal and the 4th Quarter
Straying from these names could land you in quicksand as the 4th quarter begins.
Jim Cramer: Valuations Now Have No Relation to Common Sense
Analyst downgrades and mind-boggling P/E ratios do not matter in this current market.
3 Ways to Play Lululemon on This Rise: Market Recon
LULU is up 70% since March. This is how to get into the name in an intelligent way.
Jim Cramer: 5 Sectors to Buy on This 'Turkish Contagion' Market Drop
It is all about perception, and here are strong names to pick up on market weakness.
Jim Cramer: Tech Can't Do it All Alone
Tech and retail gains aren't enough to lead markets to new highs.
Jim Cramer: Stocks That Do Well In a Declining Rate Environment Are Back
The crash of oil will only accelerate the move.
Medtronic's Rally Doesn't Look All That Healthy
Charts say the medical-devices firm should have a price target 16% above current levels, but one indicator fails to confirm that.
Jim Cramer: We Have Some Strong Opportunities to Make Some Money Here
All of these stocks are standard go-to names when inflation is peaking.
Easing Dodd-Frank Regulations on Smaller Banks Was Long Overdue: How to Play It
Relief is on the way, and there's an inexpensive beneficiary out in California.
These Stocks Are Showing Reversal Patterns
A look at stocks seeing bullish and bearish reversal characteristics over the past week.
